# A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)

> **NCT06568627** · PHASE3 · RECRUITING · sponsor: **MediWound Ltd** · enrollment: 216 (estimated)

## Conditions studied

- Venous Leg Ulcer (VLU)

## Interventions

- **DRUG:** EscharEx (EX-03)
- **DRUG:** Placebo (Gel vehicle)

## Key facts

- **NCT ID:** NCT06568627
- **Lead sponsor:** MediWound Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-01
- **Primary completion:** 2026-12
- **Final completion:** 2027-03
- **Target enrollment:** 216 (ESTIMATED)
- **Last updated:** 2026-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06568627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06568627, "A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06568627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*